Discovery of kidney cancer driver could lead to new treatment strategy

(UNC Lineberger Comprehensive Cancer Center) In a study published in the journal Science, researchers suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.